Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 2196419)

Published in Neurotoxicol Teratol on August 23, 1990

Authors

T M Burbacher1, P M Rodier, B Weiss

Author Affiliations

1: Department of Environmental Health, University of Washington, Seattle 98195.

Articles citing this

Autism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay area. Environ Health Perspect (2006) 2.67

Mechanisms underlying Children's susceptibility to environmental toxicants. Environ Health Perspect (2000) 2.63

Methylmercury and nutrition: adult effects of fetal exposure in experimental models. Neurotoxicology (2008) 1.57

Developing brain as a target of toxicity. Environ Health Perspect (1995) 1.56

Low level methylmercury exposure affects neuropsychological function in adults. Environ Health (2003) 1.43

Neurobehavioral effects of developmental methylmercury exposure. Environ Health Perspect (1995) 1.42

Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect (2005) 1.42

Does methylmercury have a role in causing developmental disabilities in children? Environ Health Perspect (2000) 1.35

Prenatal methylmercury exposure and children: neurologic, developmental, and behavioral research. Environ Health Perspect (1998) 1.25

Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary. Environ Health Perspect (2000) 1.13

Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis (2014) 1.08

Evolution of our understanding of methylmercury as a health threat. Environ Health Perspect (1996) 1.08

Gestational exposure to methylmercury and selenium: effects on a spatial discrimination reversal in adulthood. Neurotoxicology (2006) 1.06

A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect (2008) 1.05

Eyeblink conditioning in the infant rat: an animal model of learning in developmental neurotoxicology. Environ Health Perspect (1994) 1.04

The developing brain and the environment: an introduction. Environ Health Perspect (2000) 1.03

Neurotoxicity of lead, methylmercury, and PCBs in relation to the Great Lakes. Environ Health Perspect (1995) 1.01

Relationships among mercury, selenium, and neurochemical parameters in common loons (Gavia immer) and bald eagles (Haliaeetus leucocephalus). Ecotoxicology (2007) 0.97

Organic and inorganic mercury in neonatal rat brain after prenatal exposure to methylmercury and mercury vapor. Environ Health Perspect (2010) 0.97

Vulnerable periods and processes during central nervous system development. Environ Health Perspect (1994) 0.94

Hormetic effect of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol (2010) 0.92

Inorganic nutrients and contaminants in subsistence species of Alaska: linking wildlife and human health. Int J Circumpolar Health (2009) 0.91

Neural stem cell apoptosis after low-methylmercury exposures in postnatal hippocampus produce persistent cell loss and adolescent memory deficits. Dev Neurobiol (2013) 0.90

Spatial and visual discrimination reversals in adult and geriatric rats exposed during gestation to methylmercury and n-3 polyunsaturated fatty acids. Neurotoxicology (2007) 0.90

Mercury concentrations in hair from neonatal and juvenile Steller Sea Lions (Eumetopias jubatus): implications based on age and region in this northern Pacific marine sentinel piscivore. Ecohealth (2012) 0.90

Lessons for neurotoxicology from selected model compounds: SGOMSEC joint report. Environ Health Perspect (1996) 0.89

A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast. Toxicol Sci (2010) 0.86

Prenatal Programming and Toxicity (PPTOX) Introduction. Endocrinology (2015) 0.85

Developmental neurotoxicity: some old and new issues. ISRN Toxicol (2012) 0.84

Investigations of methylmercury-induced alterations in neurogenesis. Environ Health Perspect (2002) 0.82

The Role of skn-1 in methylmercury-induced latent dopaminergic neurodegeneration. Neurochem Res (2013) 0.82

A systems-based approach to investigate dose- and time-dependent methylmercury-induced gene expression response in C57BL/6 mouse embryos undergoing neurulation. Birth Defects Res B Dev Reprod Toxicol (2010) 0.81

Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.81

Methylmercury induced toxicogenomic response in C57 and SWV mouse embryos undergoing neural tube closure. Reprod Toxicol (2010) 0.80

Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol (2015) 0.80

Behavioral effects of developmental methylmercury drinking water exposure in rodents. J Trace Elem Med Biol (2013) 0.77

Effect of PCBs on the lactational transfer of methyl mercury in mice: PBPK modeling. Environ Toxicol Pharmacol (2009) 0.77

Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol (2016) 0.77

Considerations on methylmercury (MeHg) treatments in in vitro studies. Neurotoxicology (2012) 0.76

Effects of Methyl Mercury Chloride on Rat Hippocampus Structure. Biol Trace Elem Res (2015) 0.75

Is Low Non-Lethal Concentration of Methylmercury Really Safe? A Report on Genotoxicity with Delayed Cell Proliferation. PLoS One (2016) 0.75

Methylmercury inhibits prolactin release in a cell line of pituitary origin. Braz J Med Biol Res (2015) 0.75

Early Developmental Low-Dose Methylmercury Exposure Alters Learning and Memory in Periadolescent but Not Young Adult Rats. Biomed Res Int (2016) 0.75

Mercury in soil, earthworms and organs of voles Myodes glareolus and shrew Sorex araneus in the vicinity of an industrial complex in Northwest Russia (Cherepovets). Environ Monit Assess (2017) 0.75

Articles by these authors

(truncated to the top 100)

A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05

Enzymatic breakage and joining of deoxyribonucleic acid. VI. Further purification and properties of polynucleotide ligase from Escherichia coli infected with bacteriophage T4. J Biol Chem (1968) 7.09

Enzymatic breakage and joining of deoxyribonucleic acid, I. Repair of single-strand breaks in DNA by an enzyme system from Escherichia coli infected with T4 bacteriophage. Proc Natl Acad Sci U S A (1967) 5.98

Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol (1986) 5.32

Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet (1997) 4.95

Transient accumulation of Okazaki fragments as a result of uracil incorporation into nascent DNA. Proc Natl Acad Sci U S A (1977) 4.83

Enzymatic breakage and joining of deoxyribonucleic acid. V. End group labeling and analysis of deoxyribonucleic acid containing single straned breaks. J Biol Chem (1968) 4.65

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

soxR, a locus governing a superoxide response regulon in Escherichia coli K-12. J Bacteriol (1990) 4.26

Two divergently transcribed genes, soxR and soxS, control a superoxide response regulon of Escherichia coli. J Bacteriol (1991) 3.81

Mutants of Escherichia coli with altered deoxyribonucleases. I. Isolation and characterization of mutants for exonuclease 3. J Mol Biol (1972) 3.65

Exonuclease III of Escherichia coli K-12, an AP endonuclease. Methods Enzymol (1980) 3.50

Endonuclease IV of Escherichia coli is induced by paraquat. Proc Natl Acad Sci U S A (1987) 3.20

Effects of a concurrent task on fixed-interval responding in humans. J Exp Anal Behav (1963) 3.05

Genetic mapping of xthA, the structural gene for exonuclease III in Escherichia coli K-12. J Bacteriol (1976) 3.01

Specific mutator effects of ung (uracil-DNA glycosylase) mutations in Escherichia coli. J Bacteriol (1982) 2.92

Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol Pharmacol (1977) 2.90

Mutations simultaneously affecting endonuclease II and exonuclease III in Escherichia coli. Proc Natl Acad Sci U S A (1975) 2.89

Drowning mortality in Los Angeles County, 1976 to 1984. JAMA (1988) 2.89

Endonuclease III (nth) mutants of Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.72

Two-stage induction of the soxRS (superoxide response) regulon of Escherichia coli. J Bacteriol (1992) 2.71

Further observations on overt "mediating" behavior and the discrimination of time. J Exp Anal Behav (1969) 2.64

Effects of psychotherapy with children and adolescents revisited: a meta-analysis of treatment outcome studies. Psychol Bull (1995) 2.59

Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol (1998) 2.58

A computer analysis of serial interactions in spaced responding. J Exp Anal Behav (1966) 2.34

Endonuclease II of Escherichia coli is exonuclease III. J Biol Chem (1976) 2.27

Role of exonuclease III in the base excision repair of uracil-containing DNA. J Bacteriol (1982) 2.23

Mass screening for mutants with altered DNases by microassay techniques. Methods Enzymol (1974) 2.18

Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. J Consult Clin Psychol (1995) 2.17

Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther (1979) 2.15

Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. Adv Cyclic Nucleotide Res (1978) 2.12

The lab versus the clinic. Effects of child and adolescent psychotherapy. Am Psychol (1992) 2.11

Escherichia coli mutants deficient in deoxyuridine triphosphatase. J Bacteriol (1978) 2.02

Pharmacological regulation of calmodulin. Ann N Y Acad Sci (1980) 2.02

Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. Mol Pharmacol (1976) 2.02

The 5'-terminal dinucleotides of the separated strands of T7 bacteriophage deoxyribonucleic acid. J Mol Biol (1967) 2.01

Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98

SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form. Proc Natl Acad Sci U S A (1996) 1.94

Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev (1966) 1.89

Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J Bacteriol (1988) 1.89

Behavioral responses to artificial food colors. Science (1980) 1.82

Regulation of the soxRS oxidative stress regulon. Reversible oxidation of the Fe-S centers of SoxR in vivo. J Biol Chem (1997) 1.77

A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75

Microassay of adenosine-3',5'-monophosphate (cyclic AMP) in brain and other tissues by the luciferin-luciferase system. J Neurochem (1971) 1.69

Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl (2009) 1.69

Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol (1980) 1.66

Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. Proc Natl Acad Sci U S A (1991) 1.64

Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62

Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. Biochim Biophys Acta (1978) 1.59

The development of fixed-ratio performance under the influence of ribonucleic acid. J Exp Anal Behav (1972) 1.58

The microanalysis of fixed-interval responding. J Exp Anal Behav (1983) 1.58

Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg (2004) 1.56

Influence of drugs on behavior controlled by internal and external stimuli. J Pharmacol Exp Ther (1966) 1.56

Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry (2006) 1.52

Commercial talc and talcosis. Arch Environ Health (1967) 1.51

Familial contexts of adolescent ego development. Child Dev (1984) 1.48

Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J Pharmacol Exp Ther (1982) 1.47

Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. Biochem Pharmacol (1982) 1.43

Ezymatic breakage and joining of deoxyribonucleic acid. VII. Properties of the enzyme-adenylate intermediate in the polynucleotide ligase reaction. J Biol Chem (1968) 1.42

Effectiveness of psychotherapy with children and adolescents: a meta-analysis for clinicians. J Consult Clin Psychol (1987) 1.42

Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther (1987) 1.37

Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol (2000) 1.37

Giving up on child psychotherapy: who drops out? J Consult Clin Psychol (1987) 1.37

Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet (2009) 1.36

Overproduction and physical characterization of SoxR, a [2Fe-2S] protein that governs an oxidative response regulon in Escherichia coli. J Biol Chem (1995) 1.36

Oligonucleotide mapping studies of standard and defective Sindbis virus RNA. J Virol (1979) 1.36

Studies on the joining of DNA by polynucleotide ligase of phage T4. Cold Spring Harb Symp Quant Biol (1968) 1.35

Mutants of Escherichia coli with altered deoxyribonucleases. II. Isolation and characterization of mutants for exonuclease I. J Mol Biol (1974) 1.35

Parent reports of behavioral and emotional problems among children in Kenya, Thailand, and the United States. Child Dev (1993) 1.34

A microanalysis of drug effects on fixed-ratio performance in pigeons. J Pharmacol Exp Ther (1972) 1.33

Human Observing Behavior after Signal Detection. J Exp Anal Behav (1960) 1.33

Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol Sci (1988) 1.32

A study of conidiation in Neurospora crassa. J Gen Microbiol (1966) 1.31

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30

Chronology of neuron development: animal studies and their clinical implications. Dev Med Child Neurol (1980) 1.30

dfp Gene of Escherichia coli K-12, a locus affecting DNA synthesis, codes for a flavoprotein. J Bacteriol (1985) 1.29

Defective interfering passages of Sindbis virus: chemical composition, biological activity, and mode of interference. J Virol (1973) 1.29

Defective interfering passages of Sindbis virus: nature of the defective virion RNA. J Virol (1976) 1.28

Multiple mutant of Escherichia coli synthesizing virtually thymineless DNA during limited growth. J Bacteriol (1992) 1.28

Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience (1993) 1.26

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects. Environ Health Perspect (2001) 1.26

Preliminary mapping of mutations affecting exonuclease 3 in Escherichia coli K-12. J Bacteriol (1973) 1.26

Cloning of the exonuclease III gene of Escherichia coli. Gene (1980) 1.25

dcd (dCTP deaminase) gene of Escherichia coli: mapping, cloning, sequencing, and identification as a locus of suppressors of lethal dut (dUTPase) mutations. J Bacteriol (1992) 1.24

Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A (1978) 1.23

Terminal cross-linking of DNA strands by an enzyme system from Escherichia coli infected with bacteriophage T4. Proc Natl Acad Sci U S A (1970) 1.20

Cloning of the dut (deoxyuridine triphosphatase) gene of Escherichia coli. Gene (1980) 1.20

Endonuclease V protects Escherichia coli against specific mutations caused by nitrous acid. Mutat Res (1999) 1.19

Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill (2007) 1.19

Genetic mapping of nth, a gene affecting endonuclease III (thymine glycol-DNA glycosylase) in Escherichia coli K-12. J Bacteriol (1985) 1.19

Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol (1989) 1.18

Behavioral and emotional problems among Thai and American adolescents: parent reports for ages 12-16. J Abnorm Psychol (1993) 1.17

Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology (2000) 1.16

Structural--functional relationships in experimentally induced brain damage. Prog Brain Res (1988) 1.15

Fluttering of the mitral valve in aortic insufficiency. Circulation (1970) 1.14

Food additives and environmental chemicals as sources of childhood behavior disorders. J Am Acad Child Psychiatry (1982) 1.14

The clearance of manganese chloride in the primate. Fundam Appl Toxicol (1987) 1.13

Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. Neurobehav Toxicol Teratol (1985) 1.10

Prenatal methyl mercury exposure in relation to neurodevelopment and behavior at 19 years of age in the Seychelles Child Development Study. Neurotoxicol Teratol (2013) 1.10

A human pseudoautosomal gene, ADP/ATP translocase, escapes X-inactivation whereas a homologue on Xq is subject to X-inactivation. Nat Genet (1993) 1.09